[3D Tumor organoid models produced by cellular capsules technology CCT]

Bull Cancer. 2022 Jan;109(1):38-48. doi: 10.1016/j.bulcan.2021.12.001. Epub 2022 Jan 5.
[Article in French]

Abstract

Monolayer cultures of cell lines and derived-patient cells have long been the in vitro model of choice in oncology. In particular, these models have made it possible to decipher the mechanisms that determine tumor proliferation and invasion. However these 2D models are insufficient because they do not take into account the spatial organization of cells and their interactions with each other or with the extracellular matrix. In the context of cancer, there is a need to develop new 3D (tumoroid) models in order to gain a better understanding of the development of these pathologies but also to assess the penetration of drugs through a tissue and the associated cellular response. We present here the cell capsule technology (CCT), which allows the production of different tumoroid models: simple or more complex 3D culture models including co-culture of tumor cells with components of the microenvironment (fibroblasts, matrix, etc.). The development of these new 3D culture systems now makes it possible to propose refined physiopathological models that will allow the implementation of improved targeted therapeutic strategies.

Keywords: 3D culture; Alginate; Capsule; Culture 3D; Organoids; Organoïdes; Spheroids; Sphéroïdes.

Publication types

  • Review

MeSH terms

  • Alginates
  • Cancer-Associated Fibroblasts
  • Cell Communication
  • Cell Culture Techniques, Three Dimensional / methods*
  • Cell Encapsulation / methods*
  • Cell Proliferation
  • Coculture Techniques / methods
  • Epithelial-Mesenchymal Transition
  • Extracellular Matrix / chemistry
  • Humans
  • Neoplasm Invasiveness
  • Organoids*
  • Spheroids, Cellular*
  • Tumor Cells, Cultured
  • Tumor Microenvironment

Substances

  • Alginates